GLP-1 Articles | Knowledge Hub

Semaglutide vs Tirzepatide for Metabolic Research

A head-to-head comparison of semaglutide and tirzepatide examining mechanisms, clinical efficacy, and side effect profiles. Discover how single vs dual agonism ...

Comparisons 5 min read

Read ›

Semaglutide vs Retatrutide: Single vs Triple Agonist Metabolic Research

Compare semaglutide's GLP-1 mono-agonism against retatrutide's triple GLP-1/GIP/glucagon receptor activation. Explore how the triple agonist approach achieves u...

Comparisons 5 min read

Read ›

Tirzepatide vs Retatrutide: Dual vs Triple Agonist Metabolic Peptides

Compare tirzepatide's dual GLP-1/GIP agonism with retatrutide's triple GLP-1/GIP/glucagon receptor activation. Analyze whether the addition of glucagon agonism ...

Comparisons 5 min read

Read ›

Orforglipron vs Semaglutide: Oral Small Molecule vs Injectable Peptide GLP-1 Agonists

Compare orforglipron, the first oral non-peptide GLP-1 agonist, with injectable semaglutide. Explore how a small molecule approach to GLP-1 agonism could transf...

Comparisons 5 min read

Read ›

Analyzing Retatrutide Mechanisms for Weight Loss

An in-depth analysis of retatrutide (LY3437943), the first triple GLP-1/GIP/glucagon receptor agonist, and its mechanisms for unprecedented weight loss in clini...

Weight Loss and Metabolic Health 2 min read

Read ›

Clinical Comparison of Tirzepatide and Semaglutide Efficacy

A head-to-head clinical comparison of tirzepatide and semaglutide - examining efficacy, mechanisms, side effects, and which GLP-1 therapy shows superior outcome...

Weight Loss and Metabolic Health 2 min read

Read ›